EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mutually Reinforcing Polyphenol and Nanomedicines: Unlocking the Potential of Polyphenol‐Based Nanodrugs for Liver Injury Therapy

Min Liu, Rui Huang, Shuya Wang, Yuting Lin, Tingli Xiong, Ruishi Li, Wenxuan Zheng, Qiong Huang iD, Yayun Nan, Zhaoqian Liu iD, Kelong Ai

Advanced Healthcare Materials · 2026-07 · 15 (25)

DOI: 10.1002/adhm.71320 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 08.06.2026. Verfasst von Min Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China. Hauptthemen laut MEDLINE: Polyphenols, Nanomedicine, Nanoparticles, Chemical and Drug Induced Liver Injury. Die Arbeit nennt 404 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Hunan Province, Key Research Project of Ningxia Hui Autonomous Region of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The liver performs around a thousand essential functions, including metabolism, detoxification, and immune regulation. However, its constant exposure to harmful substances, such as alcohol, drugs, and toxins, makes it prone to injury. Persistent exposure drives liver disease progression, which causes about ∼4% of all deaths annually. Current treatments for liver injury, which combine targeted and supportive care, remain limited by poor drug delivery and efficacy. Anti‐inflammatory and antioxidant treatments are essential, yet the pathology is a complex interplay of oxidative stress, inflammation, hepatocyte death, and fibrosis, resisting simple interventions. Polyphenols are multi‐target compounds, but their efficacy is hindered by conventional drawbacks. Nanotechnology mimics nanoscale biology to improve pharmacokinetics, enable liver‐targeted delivery, and support combination therapies. Notably, polyphenols can act as building units for novel nanodrugs or modify other nanoparticles due to structural features. Thus, polyphenol‐based nanodrugs achieve efficient liver enrichment and hold unique potential to tackle multiple therapeutic challenges. Herein, this article analyzes the core pathophysiology of liver injury, elaborates on the biological activities of polyphenols and clinical challenges, and focuses on how to leverage the distinctive chemical properties of polyphenols to construct advanced nanodrugs, and how these nanodrugs can address multiple pathogenic facets of liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolyphenolsNanomedicineNanoparticlesChemical and Drug Induced Liver InjuryHumansAnimalsLiverAntioxidantsOxidative StressDrug Delivery SystemsLiver Diseases

Stichwörter der Autor:innen

liver injuryliver‐targeted deliverymetal‐polyphenol coordinationnanodrugspolyphenols

Substanzen

PolyphenolsAntioxidants

Autor:innen und Institutionen

  • Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, P. R. China.
  • Hunan Provincial Key Laboratory of Cardiovascular Research, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, P. R. China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, P. R. China.
  • Key Laboratory of Biological Nanotechnology NHC, Changsha, Hunan, P.R. China.
  • Geriatric Medical Center, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, P. R. China.

ORCID-Profile: Qiong Huang, Zhaoqian Liu

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Hunan Province
  • Key Research Project of Ningxia Hui Autonomous Region of China
  • Central South University Research Programme of Advanced Interdisciplinary Studies
  • Project Program of National Clinical Research Center for Geriatric Disorders
  • Open Research Fund of Key Laboratory of Biological Nanotechnology NHC
  • Fundamental Research Funds for the Central Universities of Central South University

Zitieren

APA

Liu, M., Huang, R., Wang, S., Lin, Y., Xiong, T., Li, R., Zheng, W., Huang, Q., Nan, Y., Liu, Z., & Ai, K. (2026). Mutually Reinforcing Polyphenol and Nanomedicines: Unlocking the Potential of Polyphenol‐Based Nanodrugs for Liver Injury Therapy. Advanced Healthcare Materials, 15(25). https://doi.org/10.1002/adhm.71320

Vancouver

Liu M, Huang R, Wang S, Lin Y, Xiong T, Li R, et al. Mutually Reinforcing Polyphenol and Nanomedicines: Unlocking the Potential of Polyphenol‐Based Nanodrugs for Liver Injury Therapy. Advanced Healthcare Materials. 2026;15(25). doi:10.1002/adhm.71320

BibTeX
@article{Liu2026,
  author = {Liu, Min and Huang, Rui and Wang, Shuya and Lin, Yuting and Xiong, Tingli and Li, Ruishi and Zheng, Wenxuan and Huang, Qiong and Nan, Yayun and Liu, Zhaoqian and Ai, Kelong},
  title = {Mutually Reinforcing Polyphenol and Nanomedicines: Unlocking the Potential of Polyphenol‐Based Nanodrugs for Liver Injury Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {25},
  doi = {10.1002/adhm.71320}
}
Kostenlos starten →